Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Azathioprine added to standard therapy for maintenance of remission in pediatric ulcerative colitis
2012-001653-13Phase 4Active
- Sponsor
- Department of Pediatrics, University of Naples Federico II
- Start
- Mar 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of azathioprine in autoimmune colitis (2 arms), sponsored by Department of Pediatrics, University of Naples Federico II. Primary endpoints: Clinical remission at 18 months and Clinical relapse or treatment failure. Started Mar 2013; status: active.
02
Drugs
azathioprine
03
Conditions
autoimmune colitis
Beyond the preview
Go deeper on 2012-001653-13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-001653-13.